BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 23178850)

  • 1. AID and Apobec3G haphazard deamination and mutational diversity.
    Jaszczur M; Bertram JG; Pham P; Scharff MD; Goodman MF
    Cell Mol Life Sci; 2013 Sep; 70(17):3089-108. PubMed ID: 23178850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-stranded DNA scanning and deamination by APOBEC3G cytidine deaminase at single molecule resolution.
    Senavirathne G; Jaszczur M; Auerbach PA; Upton TG; Chelico L; Goodman MF; Rueda D
    J Biol Chem; 2012 May; 287(19):15826-35. PubMed ID: 22362763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain.
    Feng Y; Chelico L
    J Biol Chem; 2011 Apr; 286(13):11415-26. PubMed ID: 21300806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
    Love RP; Xu H; Chelico L
    J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3G.
    Chelico L; Prochnow C; Erie DA; Chen XS; Goodman MF
    J Biol Chem; 2010 May; 285(21):16195-205. PubMed ID: 20212048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
    Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
    J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
    Kohli RM; Maul RW; Guminski AF; McClure RL; Gajula KS; Saribasak H; McMahon MA; Siliciano RF; Gearhart PJ; Stivers JT
    J Biol Chem; 2010 Dec; 285(52):40956-64. PubMed ID: 20929867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stochastic properties of processive cytidine DNA deaminases AID and APOBEC3G.
    Chelico L; Pham P; Goodman MF
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):583-93. PubMed ID: 19022738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of a single-stranded DNA-scanning process in which activation-induced deoxycytidine deaminase (AID) deaminates C to U haphazardly and inefficiently to ensure mutational diversity.
    Pham P; Calabrese P; Park SJ; Goodman MF
    J Biol Chem; 2011 Jul; 286(28):24931-42. PubMed ID: 21572036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AID: how does it aid antibody diversity?
    Honjo T; Muramatsu M; Fagarasan S
    Immunity; 2004 Jun; 20(6):659-68. PubMed ID: 15189732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AID Recognizes Structured DNA for Class Switch Recombination.
    Qiao Q; Wang L; Meng FL; Hwang JK; Alt FW; Wu H
    Mol Cell; 2017 Aug; 67(3):361-373.e4. PubMed ID: 28757211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation-induced deoxycytidine deaminase (AID) co-transcriptional scanning at single-molecule resolution.
    Senavirathne G; Bertram JG; Jaszczur M; Chaurasiya KR; Pham P; Mak CH; Goodman MF; Rueda D
    Nat Commun; 2015 Dec; 6():10209. PubMed ID: 26681117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.
    Basu U; Chaudhuri J; Alpert C; Dutt S; Ranganath S; Li G; Schrum JP; Manis JP; Alt FW
    Nature; 2005 Nov; 438(7067):508-11. PubMed ID: 16251902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of the activation-induced deoxycytidine deaminase required in immunoglobulin diversification.
    Pham P; Afif SA; Shimoda M; Maeda K; Sakaguchi N; Pedersen LC; Goodman MF
    DNA Repair (Amst); 2016 Jul; 43():48-56. PubMed ID: 27258794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutating for Good: DNA Damage Responses During Somatic Hypermutation.
    Pilzecker B; Jacobs H
    Front Immunol; 2019; 10():438. PubMed ID: 30915081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets.
    Chaudhuri J; Khuong C; Alt FW
    Nature; 2004 Aug; 430(7003):992-8. PubMed ID: 15273694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of phosphorylation and phosphorylation-null mutants on the activity and deamination specificity of activation-induced cytidine deaminase.
    Pham P; Smolka MB; Calabrese P; Landolph A; Zhang K; Zhou H; Goodman MF
    J Biol Chem; 2008 Jun; 283(25):17428-39. PubMed ID: 18417471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of in vitro DNA deamination activity and physiological functions of AID mutants.
    Shivarov V; Shinkura R; Honjo T
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15866-71. PubMed ID: 18832469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase.
    Liang G; Kitamura K; Wang Z; Liu G; Chowdhury S; Fu W; Koura M; Wakae K; Honjo T; Muramatsu M
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2246-51. PubMed ID: 23341589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.